These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 8957608)
1. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608 [TBL] [Abstract][Full Text] [Related]
2. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses. Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243 [TBL] [Abstract][Full Text] [Related]
3. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology. Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929 [TBL] [Abstract][Full Text] [Related]
4. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611 [TBL] [Abstract][Full Text] [Related]
7. [Positron emission tomography using 18-FDG-PET in radiologically indeterminate pulmonary lesions]. Ruiz-Hernández G; de Juan R; Samanes A; Verea H; Peñas JM; Veres A; Lapeña L; Montz R; Carreras JL An Med Interna; 2004 Jan; 21(1):12-6. PubMed ID: 15195479 [TBL] [Abstract][Full Text] [Related]
8. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. Matthies A; Hickeson M; Cuchiara A; Alavi A J Nucl Med; 2002 Jul; 43(7):871-5. PubMed ID: 12097455 [TBL] [Abstract][Full Text] [Related]
9. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
10. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Gupta N; Gill H; Graeber G; Bishop H; Hurst J; Stephens T Chest; 1998 Oct; 114(4):1105-11. PubMed ID: 9792584 [TBL] [Abstract][Full Text] [Related]
11. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399 [TBL] [Abstract][Full Text] [Related]
12. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877 [TBL] [Abstract][Full Text] [Related]
13. Differentiating benign and malignant pulmonary lesions with FDG-PET. Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
15. Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET. Núñez R; Kalapparambath A; Varela J Rev Esp Med Nucl; 2007; 26(4):196-207. PubMed ID: 17662186 [TBL] [Abstract][Full Text] [Related]
17. Can dynamic imaging, using Marin A; Murchison JT; Skwarski KM; Tavares AAS; Fletcher A; Wallace WA; Salapura V; van Beek EJR; Mirsadraee S Radiol Oncol; 2021 May; 55(3):259-267. PubMed ID: 34051709 [TBL] [Abstract][Full Text] [Related]
18. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920 [TBL] [Abstract][Full Text] [Related]
19. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Dewan NA; Reeb SD; Gupta NC; Gobar LS; Scott WJ Chest; 1995 Aug; 108(2):441-6. PubMed ID: 7634881 [TBL] [Abstract][Full Text] [Related]
20. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules. Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]